J&J Ditropan XL Goes Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Impax/Teva launching 15 mg strength, and Mylan joins with "authorized" generic as well as its own version of the 5 mg and 10 mg strengths.
You may also be interested in...
FDA: J&J’s Ditropan Labeling Should Be Strengthened To Advise Of Hallucinations
Documents issued ahead of a Pediatric Advisory Committee meeting April 11 urge stronger caution due to CNS effects of oxybutynin.
FDA: J&J’s Ditropan Labeling Should Be Strengthened To Advise Of Hallucinations
Documents issued ahead of a Pediatric Advisory Committee meeting April 11 urge stronger caution due to CNS effects of oxybutynin.
FDA “First Generics” Policy Not Enough, Mylan CEO Says
Agency's ANDA review needs a top-to-bottom policy overhaul to end approval delays, Coury says.